Capital Point Ltd. (TASE:CPTP) and Meytag High Tech Ventures sold 17.84% stake in Lithotech Medical, Ltd. for ILS 15.9 million on December 15, 2016. As part of the consideration, ILS 10 million will be paid upon completion of the deal and ILS 3 million will be paid subject to milestones regarding Lithotech’s incomes during 2016 and 2017. In addition, a total of about ILS 1.6 million will be held by a trust in benefit of the sellers, when the amount is supposed to ensure the fulfillment of the representations provided by the sellers to the buyer and an additional amount of ILS 1.3 million will be held by the trustee, to be used as guarantee. Capital Point Ltd. (TASE:CPTP) and Meytag High Tech Ventures completed the sale of 17.84% stake in Lithotech Medical, Ltd. on December 15, 2016.